Cargando…

Blood DNA Methylation Levels in the WNT5A Gene Promoter Region: A Potential Biomarker for Agitation in Subjects with Dementia

BACKGROUND: Behavioral and psychological symptoms of dementia (BPSD) cause a heavy burden for both patient and caregivers. These symptoms are diverse, and their mechanism is still unclear. Agitation is the most common and difficult to treat among BPSD. In recent years, while changes in DNA methylati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Nobuyuki, Shinagawa, Shunichiro, Nagata, Tomoyuki, Tagai, Kenji, Shimada, Kazuya, Ishii, Azusa, Oka, Naomi, Shigeta, Masahiro, Kondo, Kazuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293647/ https://www.ncbi.nlm.nih.gov/pubmed/33967051 http://dx.doi.org/10.3233/JAD-210078

Ejemplares similares

Increased blood COASY DNA methylation levels a potential biomarker for early pathology of Alzheimer’s disease
por: Kobayashi, Nobuyuki, et al.
Publicado: (2020)

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients
por: Kobayashi, Nobuyuki, et al.
Publicado: (2022)

A case of V180I genetic mutation Creutzfeldt Jakob disease (CJD) with delusional misidentification as an initial symptom
por: Nagata, Tomoyuki, et al.
Publicado: (2021)

Human Herpesvirus 6B Greatly Increases Risk of Depression by Activating Hypothalamic-Pituitary -Adrenal Axis during Latent Phase of Infection
por: Kobayashi, Nobuyuki, et al.
Publicado: (2020)

SARS-CoV-2 S1 protein causes brain inflammation by reducing intracerebral acetylcholine production
por: Oka, Naomi, et al.
Publicado: (2023)

VP26, a herpes simplex virus type 1 capsid protein, increases DNA methylation in COASY promoter region
por: Osaka, Rui, et al.
Publicado: (2022)

Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer’s Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2022)

Development of Biomarkers Based on DNA Methylation in the NCAPH2/LMF2 Promoter Region for Diagnosis of Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Usefulness of DNA Methylation Levels in COASY and SPINT1 Gene Promoter Regions as Biomarkers in Diagnosis of Alzheimer’s Disease and Amnestic Mild Cognitive Impairment
por: Kobayashi, Nobuyuki, et al.
Publicado: (2016)

Association between DNA Methylation of the BDNF Promoter Region and Clinical Presentation in Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2015)

Longitudinal Changes in the Government-Certified Index Stage and Requisite Costs for Long-Term Care Insurance System among the Community-Dwelling Demented Elderly in Japan
por: Shinagawa, Shunichiro, et al.
Publicado: (2013)

Genetic Association between Presenilin 2 Polymorphisms and Alzheimer's Disease and Dementia of Lewy Body Type in a Japanese Population
por: Suzuki, Ayako, et al.
Publicado: (2016)

Neuroimaging-derived brain age is associated with life satisfaction in cognitively unimpaired elderly: A community-based study
por: Sone, Daichi, et al.
Publicado: (2022)

Discomfort and agitation in older adults with dementia
por: Pelletier, Isabelle Chantale, et al.
Publicado: (2007)

Gabapentin in the treatment of dementia-associated nocturnal agitation
por: Buskova, Jitka, et al.
Publicado: (2011)

Stress Cardiomyopathy in Association with Severe Agitation in Dementia
por: Amin, Hina, et al.
Publicado: (2019)

ELECTROCONVULSIVE THERAPY FOR AGITATION IN LEWY BODIES DEMENTIA
por: Echeverria, C., et al.
Publicado: (2023)

Behavior management approach for agitated behavior in Japanese patients with dementia: a pilot study
por: Sato, Junko, et al.
Publicado: (2013)

Effects of Music on Agitation in Dementia: A Meta-Analysis
por: Pedersen, Siv K. A., et al.
Publicado: (2017)

Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
por: Tampi, Rajesh R, et al.
Publicado: (2020)

Management of Agitation in Dementia and Effects on Inpatient Length of Stay
por: Silverstone-Simard, Isabelle, et al.
Publicado: (2021)

Challenges of Agitation in Dementia: A Plea for Early Discussion
por: Richler, Leah G., et al.
Publicado: (2023)

A reflection on the use of Antidepressants to manage agitation in dementia
por: Basto, M.D.R.D.R.F.D., et al.
Publicado: (2022)

Agitation in Dementia: Relation to Core Cerebrospinal Fluid Biomarker Levels
por: Bloniecki, Victor, et al.
Publicado: (2014)

Measuring Electrodermal Activity to Improve the Identification of Agitation in Individuals with Dementia
por: Melander, Catharina, et al.
Publicado: (2017)

Agitation near the end of life with dementia: An ethnographic study of care
por: Sampson, Elizabeth L., et al.
Publicado: (2019)

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
por: Carrarini, Claudia, et al.
Publicado: (2021)

The Impact of Agitation in Dementia on Caregivers: A Real-World Survey
por: Schein, Jeff, et al.
Publicado: (2022)

Toward Quantification of Agitation in People With Dementia Using Multimodal Sensing
por: Davidoff, Hannah, et al.
Publicado: (2022)

Novel Gene Therapy Viral Vector Using Non-Oncogenic Lymphotropic Herpesvirus
por: Shimizu, Akihiro, et al.
Publicado: (2013)

REJECTION OF CARE, AGGRESSION, AND AGITATION IN PERSONS WITH DEMENTIA: A REVIEW OF DEFINITIONS IN DEMENTIA MEASURES
por: Choi, Scott, et al.
Publicado: (2019)

Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study
por: Panca, Monica, et al.
Publicado: (2019)

Relationship between human herpesvirus 6 infection and inflammatory bowel disease using novel biomarker
por: Matsumoto, Satohiro, et al.
Publicado: (2023)

Age-Related Association between Apolipoprotein E ε4 and Cognitive Function in Japanese Patients with Alzheimer's Disease
por: Nagata, Tomoyuki, et al.
Publicado: (2013)

Comparison of the efficacy of aroma-acupressure and aromatherapy for the treatment of dementia-associated agitation
por: Yang, Man-Hua, et al.
Publicado: (2015)

Individual music therapy for agitation in dementia: an exploratory randomized controlled trial
por: Ridder, Hanne Mette O., et al.
Publicado: (2013)

Agitated behaviors among elderly people with dementia living in their home in Taiwan
por: Huang, Huei-Ling, et al.
Publicado: (2018)

Sequential drug treatment algorithm for agitation and aggression in Alzheimer’s and mixed dementia
por: Davies, Simon JC, et al.
Publicado: (2018)

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System
por: Jones, Eddie, et al.
Publicado: (2021)

Specific agitation behaviours in dementia differentially contribute to aspects of caregiver burden
por: Patrick, Karlee S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jt0itintqq0jdjv58prtkoicf4